Case Study

Container Selection For A Highly Sensitive Drug Product: A Success Story

stevanatogroup_light_obscuration

Selecting the right container for highly sensitive drug products is crucial to ensure their stability and efficacy, making it essential that pharmaceutical companies utilize the experience of container suppliers as early as possible. An experienced supplier offers a deep understanding of the primary packaging and can support the multifaceted, complex analysis required to select the appropriate primary container, especially if it is to be integrated into a device. In this case study, review how Stevanato Group was able to support one of its clients every step of the way, forging a successful longterm partnership and finding the right solution for each unique situation.

Following a comprehensive analysis evaluating various container options and testing their suitability, Stevanato Group ultimately chose Alba® syringes as the optimal solution for their client, a pharmaceutical company.

Alba® syringes are a breakthrough technology for biologics, improving upon standard silicone by cross-linking it for increased stability. Alba® syringes coating provide consistent and predictable gliding force, making them suitable for auto-injector performance. Test data shows that the Alba® syringes consistently perform well, even after storage, meeting clients' performance requirements.

Examine the importance of selecting the right primary packaging for sensitive drug products and discover how close collaboration is crucial for avoiding commercialization delays and safety risks to patients.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online